Clinical trial NCT04540653 - References

Aging — Immunogenicity of the Hepatitis B Vaccine

Citation(s)

•   Aguiar RB, Leal MCC, Marques APO, Torres KMS, Tavares MTDB
  [Elderly people living with HIV - behavior and knowledge about sexuality: an integrative review]. Cien Saude Colet. 2020 Feb;25(2):575-584. doi: 10.1590/1413-81232020252.12052018. Epub 2018 Jun 27. Portuguese.
•   Bastos LM, Tolentino JMS, Frota MAO, Tomaz WC, Fialho MLS, Batista ACB, Teixeira AKM, Barbosa FCB
  [Evaluation of the level of knowledge about Aids and syphilis among the elderly from a city in the interior of the state of Ceará, Brazil]. Cien Saude Colet. 2018 Aug;23(8):2495-2502. doi: 10.1590/1413-81232018238.10072016. Portuguese.
•   BLUMBERG BS, ALTER HJ, VISNICH S
  A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541-6.
•   Caetano KA, Del-Rios NH, Pinheiro RS, Bergamaschi FP, Carneiro MA, Teles SA
  Low Immunogenicity of Recombinant Hepatitis B Vaccine Derived from Hansenula polymorpha in Adults Aged Over 40 Years. Am J Trop Med Hyg. 2017 Jan 11;96(1):118-121. doi: 10.4269/ajtmh.16-0475. Epub 2016 Oct 31.
•   Gerlich WH
  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015 Feb;204(1):39-55. doi: 10.1007/s00430-014-0373-y. Epub 2014 Dec 19. Review.
•   Gilbert CL, Klopfer SO, Martin JC, Schödel FP, Bhuyan PK
  Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults =50 years. Hum Vaccin. 2011 Dec;7(12):1336-42. doi: 10.4161/hv.7.12.18333. Epub 2011 Dec 1.
•   Liu Z, Yang Q, Shi O, Ye W, Chen X, Zhang T
  The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study. J Viral Hepat. 2018 Dec;25(12):1543-1554. doi: 10.1111/jvh.12938. Epub 2018 Jun 20.
•   Lyons A, Heywood W, Fileborn B, Minichiello V, Barrett C, Brown G, Hinchliff S, Malta S, Crameri P
  The Sex, Age, and Me study: recruitment and sampling for a large mixed-methods study of sexual health and relationships in an older Australian population. Cult Health Sex. 2017 Sep;19(9):1038-1052. doi: 10.1080/13691058.2017.1288268. Epub 2017 Feb 21.
•   Minichiello V, Rahman S, Hawkes G, Pitts M
  STI epidemiology in the global older population: emerging challenges. Perspect Public Health. 2012 Jul;132(4):178-81. doi: 10.1177/1757913912445688. Review.
•   Monsell E, McLuskey J
  Factors influencing STI transmission in middle-aged heterosexual individuals. Br J Nurs. 2016 Jun 23;25(12):676-80. doi: 10.12968/bjon.2016.25.12.676. Review.
•   Rosenberg C, Bovin NV, Bram LV, Flyvbjerg E, Erlandsen M, Vorup-Jensen T, Petersen E
  Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccin Immunother. 2013 Jul;9(7):1466-76. doi: 10.4161/hv.24480. Epub 2013 Apr 9.
•   Sagnelli E, Stroffolini T, Sagnelli C, Morisco F, Coppola N, Smedile A, Pisaturo M, Colloredo G, Babudieri S, Licata A, Brancaccio G, Andriulli A, Almasio PL, Gaeta GB; EPACRON study group
  Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study. J Med Virol. 2017 Dec;89(12):2138-2143. doi: 10.1002/jmv.24873. Epub 2017 Aug 29.
•   Sharma R, Ahlm C, Ostergaard L, Dowell A, Tran C, Thomas S, Eymin C
  Persistence of immunity in healthy adults aged = 50 years primed with a hepatitis B vaccine 3 years previously. Hum Vaccin Immunother. 2015;11(7):1709-16. doi: 10.1080/21645515.2015.1019187.
•   Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A
  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833-41.
•   Tran TQ, Grimes CZ, Lai D, Troisi CL, Hwang LY
  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users. Vaccine. 2012 Jan 5;30(2):342-9. doi: 10.1016/j.vaccine.2011.10.084. Epub 2011 Nov 8.
•   Van Der Meeren O, Crasta P, Cheuvart B, De Ridder M
  Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis. Hum Vaccin Immunother. 2015;11(7):1726-9. doi: 10.1080/21645515.2015.1039758.
•   Vermeulen M, Swanevelder R, Chowdhury D, Ingram C, Reddy R, Bloch EM, Custer BS, Murphy EL; NHLBI Recipient Epidemiology and Donor evaluation Study-III (REDS-III) International Component
  Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa. Emerg Infect Dis. 2017 Sep;23(9):1560-1563. doi: 10.3201/eid2309.161594.

Immunogenicity of the Hepatitis B Vaccine in Individuals 50 Years Old or More: Randomized Clinical Trial

Details for clinical trial NCT04540653